VWF Deficiency Drives Angiodysplasia via Angiopoietin-2 Dysregulation
New research identifies a molecular pathway linking von Willebrand factor deficiency to gut angiodysplasia, suggesting a targeted therapeutic…
Read Article →
IV Iron Linked to Improved Survival, Anemia Recovery in Acute Infection
A retrospective cohort study suggests intravenous iron administration during acute infection does not worsen outcomes and may offer benefits.
French NOMADMUS Cohort Details AQP4+NMOSD, MOGAD Trends
A nationwide registry in France provides real-world data on diagnostic and therapeutic shifts, and disease activity in AQP4+NMOSD and MOGAD.
2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke
Acute ischemic stroke management
2C-B Shows Empathogenic and Psychedelic Effects with Low Cardiovascular Strain
A crossover trial compares 30 mg of 2C-B to MDMA and psilocybin, finding similar emotional empathy and a shorter five-hour duration.
Alzheimer’s Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer’s Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for primary care
Alzheimer's disease and related dementias
Trial Watch
No featured trials in the last 30 days.
New Guidelines
-
SCCM and ESICM launch 2026 guideline for Sepsis and Septic Shock Management
-
AHA and ACC launch 2026 guideline for Acute Pulmonary Embolism in Adults
-
AHA and ASA launch 2026 guideline for Acute Ischemic Stroke management
-
ACEP launches 2025 clinical policy for Endotracheal Intubation in the Emergency Department
-
LANCETP launches 2025 guideline for Algorithmic Treatment of Schizophrenia
-
AA and SNMMI launch 2025 guideline for Amyloid and Tau PET Appropriate Use Criteria
Latest
-
CT-Detected White Matter Disease Signals Higher Stroke/Dementia Risk Than MRI-Only Findings
-
Multiomic Analysis Reveals CTCL Progression Mechanisms, Identifies Therapeutic Targets
-
Smoking Cessation Reduces Dementia Risk, But Weight Gain May Attenuate Benefit
-
True Refractoriness to Caplacizumab in iTTP Is Rare
-
Itraconazole Inhibits OXPHOS in AML, Targets Therapy-Resistant Leukemic Stem Cells
-
ERV Reactivation Drives C4b-Mediated Synaptic Pruning in Autism Models